Skip to main content
CSL Ltd. logo

CSL Ltd. — Investor Relations & Filings

Ticker · CSL ISIN · AU000000CSL8 LEI · 529900ECSECK5ZDQTE14 ASX Manufacturing
Filings indexed 2,553 across all filing types
Latest filing 2020-07-15 Regulatory Filings
Country AU Australia
Listing ASX CSL

About CSL Ltd.

https://www.csl.com/

CSL is a global biotechnology company that researches, develops, manufactures, and markets a diverse portfolio of medicines. The company operates through distinct business units. CSL Behring provides plasma-derived and recombinant biotherapies for patients with rare and serious diseases, including bleeding disorders, immunodeficiencies, and neurological disorders. CSL Seqirus is a leading provider of vaccines, with a focus on influenza prevention and public health. CSL Vifor specializes in therapies for iron deficiency and nephrology, addressing the full spectrum of kidney disease. Collectively, CSL delivers lifesaving and life-enhancing treatments to a global patient population.

Recent filings

Filing Released Lang Actions
CSL Appoints New Non Executive Director 1 page 135.
Regulatory Filings
2020-07-15 English
CSL to acquire LateStage Gene Therapy Candidate from uniQure 3 pages 159.5KB
Regulatory Filings
2020-06-24 English
Change in Leadership of CSL's Finance Function 1 pa
Regulatory Filings
2020-06-16 English
CSL to Acquire Biotech Company Vitaeris 2 pages 130.7KB
Regulatory Filings
2020-06-08 English
CEPI CSL UQ Media Release partnering agreement 4 pages 274.0KB
Regulatory Filings
2020-06-04 English
ASA Presentation 20 pages 2.8MB
Regulatory Filings
2020-05-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.